Hollister and Heavy Grass Collaborate with Slipknot Co-Founder Shawn "Clown" Crahan on New HashBone Line

Crahan is a multi-platinum, Grammy-winning artist who has sold more than 30 million albums. Clown's signature HashBone pre-roll packs will mark the first co-branded release from the Hollister-Heavy Grass licensing agreement. The products will initially be launched on May 17th in select dispensaries in California and on DreamyDelivery.com .

Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the " Company ", " Hollister Cannabis Co. " or " Hollister ") and Heavy Grass have partnered with Slipknot co-founder Shawn "Clown" Crahan for special-edition HashBone packs featuring six half-gram pre-rolls and matches in a soft-touch matte black case. The multi-platinum, Grammy-winning artist has sold more than 30 million records with Slipknot, whose last three albums debuted at No. 1 on both the Billboard 200 and the U.K. Albums Chart.

Hollister Biosciences Inc. (CNW Group/Hollister Biosciences Inc.)

Branded with original artwork, Clown's signature HashBone line contains a potent uplifting blend of 75% indica flower and 25% Paradise Citrus bubble hash. The signature premium indica flower features an earthy citrus-rich flavor profile with sublime sedating effects. Paradise Citrus, made from crossing Tropicana Cookies and Tina, adds another layer of full-body relaxation with happy head highs and citrusy notes of orchard-fresh sour orange. Lab testing confirms the potency of these hash-infused pre-rolls with THC levels above 40%.

Shawn "Clown" Crahan is a multi-talented artist who co-founded Slipknot, directed most of its music videos and serves as one of the primary songwriters. Clown is also the creative force behind Slipknot's iconic visuals, originating the masks and uniforms, creating album covers, packaging, live staging and visuals, and all merchandise.

Heavy Grass is a California cannabis brand with deep roots in the hard rock and heavy metal music community. In 2020 (see press release dated July 28, 2020 ), Hollister entered into a licensing agreement with Heavy Grass to produce and sell co-branded cannabis products primarily through collaborations with its music partners. HashBone, a leading hash-infused pre-roll in California , is one of Hollister's signature products, and the Clown HashBone line represents the first collaborative release between Hollister , Heavy Grass and one of its artists.

"We are very excited to be launching our HashBone collaboration with Clown. We couldn't ask for a better partner and someone who is true to the plant. This partnership is our first step in combining hard rock/metal with cannabis in a truly authentic way," says Carl Saling , the Co-Founder, CEO and Director of Hollister Biosciences. "Additionally, we are happy that we get to bring Clown to market in tandem with our friends at Heavy Grass - leveraging their experience in music-inspired cannabis products will amplify our overall marketing efforts."

Clown, a long-time cannabis connoisseur, is also an advocate for its potential therapeutic benefits. He adds, "Just remember, it's medicine."

In celebration of the release of Clown Cannabis, Clown and Heavy Grass are offering a once in a lifetime Green Ticket experience. The winner of Clown's Green Ticket will receive unlimited entrance for two into any Slipknot shows in the world for the next three years. For entry details visit theheavygrass.com .

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state company with a portfolio of innovative, high-quality cannabis & hemp branded consumer products and white-labeling manufacturing. Our products are sold in 370 dispensaries across Arizona and California . Hollister Biosciences wholly-owned brand, Venom Extracts, is a category-leading brand that sold more than 4 million grams in 2020, accounting for up to 30 percent of category sales in Arizona .

Products from Hollister Biosciences Inc. include HashBone, the brand's premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products and full-spectrum high CBD pet tinctures. Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA , birthplace of the "American Biker".

Website:   www.hollisterbiosciences.co , www.hollistercannabisco.com
  Instagram: @hashbones @hollistercannabisco

About Heavy Grass
Heavy Grass is a California cannabis brand that honors the legacy and lifestyle of heavy music by plugging in, getting loud and blazing up. We work with top California cultivators to provide both high quality and high potency products to our fans at an affordable price.  We want fans to spend money on a good time, not overpriced weed. www.theheavygrass.com | @heavygrassofficial

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed "forward-looking statements". The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "would", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/hollister-and-heavy-grass-collaborate-with-slipknot-co-founder-shawn-clown-crahan-on-new-hashbone-line-301292616.html

SOURCE Hollister Biosciences Inc.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/May2021/17/c2088.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Highlights:

  • Screening closed for all sites and final participants being scheduled for dosing
  • On track for top-line 6-week primary endpoint results in late Q2

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Highlights:

  • 52-week observational follow-up study from Phase 2b reveals single 25 mg COMP360 psilocybin dose offers longer-term antidepressant effects compared to lower doses, with average efficacy for a single dose of 25mg lasting about 12 weeks and substantially longer in a subgroup
  • Findings published in the March edition of the Journal of Clinical Psychiatry

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways to Participate in Stifel Virtual CNS Forum

COMPASS Pathways Plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel Virtual CNS Forum at 11:30 am ET on March 18 th , 2025.

A live audio webcast of the presentation will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
AVECHO BIOTECHNOLOGY

Avecho and Sandoz enter Exclusive License and Development Agreement to Commercialise CBD for Insomnia in Australia

Avecho Biotechnology Limited (ASX: AVE) (“Avecho” or the “Company”) today announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG (“Sandoz”) for the commercial rights to Avecho’s Phase III cannabidiol (“CBD”) capsule for insomnia in Australia. Avecho retains the rights to commercialise the product in all other territories, with Sandoz granted a first right of refusal for these markets. Avecho’s CBD capsule aims to be the first pharmaceutical CBD product registered with the Therapeutic Goods Administration (“TGA”) as an over-the-counter medicine, which market forecasts predict could generate sales surpassing US$125M per annum in Australia2.

Keep reading...Show less

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the TD Cowen 45 th Annual Health Care Conference at 1:10 pm ET on March 3 rd , 2025.

A live audio webcast of the presentation will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass management will host a conference call at 8:00 am ET (1:00pm UK)

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×